 |
 |
 |
 |
|
 |
Previous 25 Showing Treatment 26 to 50 of 1186 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Burlington, MA USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Stanford, CA USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
New York, NY USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Boston, MA USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Worcester, MA USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA USA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
 |
San Francisco, CA USA |
 |
07/07/2009 |
 |
 |
 |
Details |
 |
A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse |
 |
San Francisco, CA USA |
 |
06/29/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse |
 |
Charlottesville, VA USA |
 |
06/29/2009 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
Durham, NC USA |
 |
06/16/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
Charlotte, NC USA |
 |
06/16/2009 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
West Palm Beach, FL USA |
 |
06/16/2009 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Oceanside, NY USA |
 |
05/20/2009 |
 |
 |
 |
Details |
 |
Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
|
 |
Bethesda, MD USA |
 |
04/22/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
 |
Bethesda, MD USA |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab, Leucovorin Rescue and Highly Active Antiretroviral Therapy
|
 |
Bethesda, MD USA |
 |
04/22/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
|
 |
Bethesda, MD USA |
 |
04/21/2009 |
 |
 |
 |
Details |
 |
A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
|
 |
Bethesda, MD USA |
 |
04/21/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
 |
Bethesda, MD USA |
 |
04/21/2009 |
 |
 |
 |
Details |
 |
Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma |
 |
Bethesda, MD USA |
 |
04/21/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma |
 |
San Francisco, CA USA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
 |
San Francisco, CA USA |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone |
 |
Cincinnati, OH USA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
 |
Houston, TX USA |
 |
04/03/2009 |
 |
 |
 |
 |
 |